PHAR

Pharming Group (PHAR)

About Pharming Group (PHAR)

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Details

Daily high

$18.46

Daily low

$18.01

Price at open

$18.40

52 Week High

$19.05

52 Week Low

$7.50

Market cap

1.3B

Dividend yield

0.00%

Volume

14,403

Avg. volume

27,307

P/E ratio

1,300.00

Pharming Group News